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Introduction
Gastrointestinal stromal tumors (GISTs) were 
first classified as a distinct type of neoplasm in 1983 
[1]. Although they are relatively rare, they are con-
sidered the most prevalent mesenchymal neoplasms 
of the digestive tract [2]. Their most common loca-
tion is the stomach, but they can also occur in other 
parts of the digestive system as well as outside of 
it (urinary bladder, extraperitoneal space) [3]. They 
are characterized by considerable clinical diversity, 
ranging from small, localized, slow-growing lesions 
to very aggressive tumors that already have massive 
metastases upon diagnosis [4, 5].
The treatment of initially resectable tumors in-
volves their removal with a margin of the surround-
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A b s t r a c t
Introduction: Although minimally invasive techniques are currently recognized as effective and validated treatment 
for small gastric gastrointestinal stromal tumors (GISTs), the role of laparoscopy is not yet established, especially in 
the institutions that have less experience in minimally invasive surgery.
Aim: To evaluate the outcomes of laparoscopic treatment of gastric gastrointestinal stromal tumors compared to the 
results obtained in a group of patients treated with conventional surgery.
Material and methods: A retrospective analysis of data collected for a group of 68 patients treated for gastric GIST 
in the period from 2002 to 2017 was performed. Forty-six patients were treated laparoscopically (group 1) and 
22 patients underwent conventional surgery (group 2). The analyzed medical data included clinical and pathomor-
phological features of removed tumors, perioperative parameters as well as short and long-term results of surgical 
treatment.
Results: Histopathological examination confirmed radical resection for all patients. No deaths were reported in the 
30-day post-operative period. Patients in group 1 had significantly shorter length of hospital stay (3 vs. 9 days), less 
intra-operative blood loss (25 vs. 175 ml) and fewer perioperative complications (13% vs. 41%) compared to group 2. 
The mean post-operative follow-up was 57 months. During this period, four patients died for reasons unrelated to 
the primary disease. None of the patients who underwent a laparoscopic procedure had a recurrence of the tumor 
in the follow-up period.
Conclusions: Laparoscopy in the treatment of gastric GISTs has unquestionable advantages, including decreased 
blood loss, reduced risk of complications, and shorter hospital stay.
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ing healthy tissue [6]. The removal of the regional 
lymphatic tissue is not required, as metastasis of 
GISTs to lymph nodes is rarely observed [7].
In the last three decades, laparoscopy has played 
an increasingly important role in the treatment of 
both benign and malignant tumors. The first report 
about use of this approach for removal of a gastric 
GIST comes from 1992 [8]. It was a small tumor with 
very low potential for malignancy. In the following 
years, the treatment of these tumors by laparoscopy 
gained increasing support. Although minimally inva-
sive techniques are currently recognized as effective 
and validated treatment for small gastric GIST, the 
role of laparoscopy is not yet established, especially 
in the institutions that have less experience in mini-
mally invasive surgery [9].
Aim
The aim of the study was to evaluate the out-
comes of laparoscopic treatment of gastric gastro-
intestinal stromal tumors compared to the results 




A  retrospective analysis of data collected for 
a  group of patients treated for gastric GIST at the 
2nd Department of General Surgery at the Jagiello-
nian University in Krakow in the period from 2002 
to 2017 was performed. The study group included 
patients with an initially resectable tumor that was 
confirmed to be a  gastric stromal neoplasm upon 
histopathological examination of the surgical spec-
imen. Patients who underwent neoadjuvant treat-
ment with tyrosine kinase inhibitors, those who at 
the time of the diagnosis had distant metastases, 
and patients with an additional malignant neoplasm 
were excluded from the study.
The analyzed medical data included clinical and 
pathomorphological features of removed tumors, 
perioperative parameters as well as short- and long-
term results of surgical treatment.
Patients were divided into two groups – those who 
were treated laparoscopically (group 1) and patients 
who underwent conventional surgery (group 2). 
Factors affecting the short- and long-term outcomes 
were compared between the two groups.
During the pre-operative period, a computed to-
mography (CT) scan and a gastroscopy with a sam-
ple for histopathological examination were per-
formed for each patient. The tumors’ potential for 
malignancy was determined according to the ESMO 
2012 guidelines. The largest dimension of the GIST 
measured during the histopathological examination 
was recorded as the tumor’s diameter. Blood loss 
and operative time were established on the basis of 
documentation prepared by surgeons and anesthe-
siologists participating in the operation. Surgery-re-
lated risk was estimated using the American Society 
of Anesthesiologists (ASA) scale, while the post-op-
erative complications were evaluated according to 
the Clavien-Dindo classification [10].
Material
In the analyzed period, 68 patients (47 women 
and 21 men) were treated for gastric GISTs at the 2nd 
Department of General Surgery at the Jagiellonian 
University in Krakow. The mean age of the patients 
was 63.75 years.
Laparoscopy was performed for 46 of the patients. 
The remaining 22 patients underwent conventional 
surgery (these patients were operated on in the first 
few years of the analyzed period). The demographics 
of the patients are presented in Table I, whereas the 
type of surgery is shown in Table II. Only the tumor 
characteristics according to the ESMO classification 
including size were significantly different. 
Ethics
The study was approved by the Ethics Com-
mittee of the Jagiellonian University (KBET/1072. 
6120.117.2018). All procedures were performed in 
accordance with the latest revision of the Declara-
tion of Helsinki.
Statistical analysis
All data were analyzed with StatSoft Statistica 
v.13. The results are presented as mean ± standard 
deviation (SD), median and interquartile range (IQR) 
when appropriate. For the purposes of further analy-
sis, the entire group of patients was divided into two 
groups. The study of categorical variables used the c2 
test of independence. The Shapiro-Wilk test was used 
to check for normal distribution of data and Student’s 
t-test was used for normally distributed quantitative 
data. For non-normally distributed quantitative vari-
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ables, the Mann-Whitney U  test was used. Results 
were considered statistically significant when the 
p-value was found to be less than 0.05. 
Results
No intra-operative tumor ruptures were reported 
regardless of the study group, and the histopatho-
logical examination confirmed radical resection (R0 
margins) for all patients. The clinical and patho-
morphological features of the removed tumors are 
shown in Table III.
None of the patients who underwent laparoscop-
ic treatment required subsequent open surgery. No 
deaths were reported in the 30-day post-operative 








Number of patients 68 46 22 –
Females, n (%) 47 (69.1) 33 (71.7) 14 (63.6) 0.4987
Males, n (%) 21 (30.9) 13 (28.3) 8 (36.4)
Age, median (IQR) 66.5 (55.5–74.5) 67 (59–75) 65 (55–70) 0.5597
BMI, median (IQR) 27.7 (25.2–32.4) 27.8 (23.9–33.1) 27.2 (26.2–31.2) 0.9802
ASA 1, n (%) 1 (1.5) 1 (2.2) – 0.0276
ASA 2, n (%) 42 (61.8) 33 (71.7) 9 (40.9)
ASA 3, n (%) 25 (36.7) 12 (26.1) 13 (59.1)
Location, n (%): 0.6814
Cardia 11 (16.2) 6 (13.0) 5 (22.7)
Lesser curvature 15 (22.1) 10 (21.7) 5 (22.7)
Greater curvature 34 (50.0) 25 (54.4) 9 (40.9)
Antrum 8 (11.7) 5 (10.9) 3 (13.7)
Histological subtypes, n (%): 0.6613
Spindle cell 46 (67.6) 30 (65.2) 16 (72.7)
Epithelioid 10 (14.7) 8 (17.4) 2 (9.1)
Mixed 12 (17.6) 8 (17.4) 4 (18.2)
ESMO risk classification, n (%): 0.0326
Very low 14 (20.6) 11 (23.9) 3 (13.6)
Low 34 (50.0) 23 (50.0) 11 (50)
Moderate 12 (17.6) 10 (21.7) 2 (9.1)
High 8 (11.8) 2 (4.4) 6 (27.3)
Diameter, median (IQR) [cm] 4.35 (3.55–5.5) 4 (3.5–5.5) 4.75 (4–7) 0.0319
Table II. Type of surgery
Laparoscopic treatment (group 1):
Wedge gastric resection using stapler 19
Local transmural gastrectomy 27
Open treatment (group 2):
Wedge gastric resection using stapler 9




Gastric gastrointestinal stromal tumors: clinical features and short- and long-term outcomes of laparoscopic resection 
179Videosurgery and Other Miniinvasive Techniques 2, April/2019
period. Patients in group 1 (treated laparoscopically) 
had a significantly shorter length of hospital stay, less 
intra-operative blood loss, and fewer perioperative 
complications (13% vs. 41%) compared to group 2 
(those who underwent open surgery). Short-term 
outcomes of treatment are shown in Table IV. Two 
patients required reoperation (both from group 1). In 
one of these patients, bleeding from the short gastric 
vessels was observed in the postoperative period. The 
other patient had symptoms of obstruction of the 
gastrointestinal tract due to narrowing of the stom-
ach by the staple line at the location of the tumor. The 
remaining complications in either study group were 
not sufficiently serious to require surgical intervention 
(grade I and II in the Clavien-Dindo classification). Two 
patients from group 1 were rehospitalized – one due 
to suspected bleeding from the upper gastrointestinal 
tract (eventually ruled out), and another due to a small 
fluid collection in the vicinity of the stomach in the 
post-operative period (managed conservatively).
The mean post-operative follow-up for all pa-
tients in the study was 57 months (6–160 months). 
During this period, 4 patients (3 from group 1 and 
1 from group 2) died for reasons unrelated to the 
primary disease. None of the patients who under-
went a  laparoscopic procedure received adjuvant 
treatment with tyrosine kinase inhibitors in the 
postoperative period, and none of them experi-
enced any symptoms indicating the recurrence 
of the tumor in the follow-up period. In the group 
treated via open surgery, 5 patients were diag-
nosed with metastatic liver tumors (median time 
before recurrence was 22 months). These patients 
were treated with imatinib. During this treatment, 
no progression of the condition was observed for 
any of the patients.
Discussion
The comparison of post-operative data for pa-
tients with gastric GISTs showed that laparoscopic 
Table III. Clinical and pathomorphological fea-






Weight loss 5 (7.4)
Heartburn 3 (4.4)
Bleeding of GI tract 18 (26.5)
Asymptomatic 15 (22.1)
Immunohistochemical phenotype:
CD 117 + 66 (97.1)
CD 34 + 48 (70.6)
DOG1 + 18 (26.5)
SMA + 6 (8.8)
Desmin + 5 (7.4)
S100 + 3 (4.4)
PKC theta + 1 (1.5)
Size:
Tumor ≤ 5 cm 46 (67.6)
Tumor > 5 cm 22 (32.4)
GISTs confirmed before operation:
Yes 20 (29.4)
No 48 (70.6)
Table IV. Short-term outcomes of treatment
Parameter Group 1 Group 2 P-value
Length of hospital stay, median (IQR) [days] 3 (3–5) 9 (8–11) < 0.0001
Operative time, median (IQR) 100 (70–120) 95 (80–150) 0.1934
Intraoperative blood loss, median (IQR) 25 (15–50) 175 (100–205) < 0.0001
Patients without complications, n (%) 40 (87.0) 13 (59) 0.0034
Clavien-Dindo 1, n (%) 3 (6.5) 2 (9.1)
Clavien-Dindo 2, n (%) 1 (2.2) 7 (31.9)
Clavien-Dindo 3, n (%) 2 (4.3) –
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surgery was associated with significantly less blood 
loss, shorter hospitalization time, and a lower num-
ber of complications. Although nearly one third of 
the tumors were larger than 5 cm, both laparoscopic 
and conventional surgery resulted in radical resec-
tion, as confirmed by macroscopic assessment and 
histological examination.
The term gastrointestinal stromal tumors (GISTs) 
was introduced in 1983 by Mazur and Clark [1]. They 
originate from the precursors of cells of Cajal [11]. 
They are typically characterized by the expression of 
CD117, which is observed for 95% of these tumors. 
Other markers associated with GISTs include CD34, 
DOG1 and – less frequently – S100, SMA or desmin 
[12]. In the present study, CD117 expression was ob-
served for 97.1% of the patients, while CD34 expres-
sion was found for 70.1% of them. The expression 
of the remaining markers was much less frequent. 
As per the current guidelines, the determination 
of these markers is key to the proper diagnosis of 
GISTs. In questionable cases, it is recommended that 
the KIT and PDGFRA genes be checked for mutation; 
this is especially significant in the case of GIST tissue 
negative for CD117 [9]. It should be emphasized that 
genetic examinations have an increasingly import-
ant role in diagnostics and treatment of many types 
of neoplasms [13].
Gastrointestinal stromal tumors can be ex-
cised with a small margin of healthy tissue without 
lymphadenectomy because they infrequently me-
tastasize to lymph nodes (fewer than 3% of cases 
based on the available literature data [6, 7]). This 
makes minimally invasive techniques particularly 
suitable for the removal of GISTs, especially gastric 
ones. The first procedure of this type was performed 
more than 25 years ago [8]. Laparoscopy is current-
ly a well-established method of treatment of small 
gastric GISTs [9]. There is a widespread opinion that 
if the team has adequate experience and will exer-
cise sufficient care to maintain sufficient tumor-free 
margins during resection, the size of the tumor itself 
does not exclude the use of minimally invasive pro-
cedures [14, 15]. Its advantages over open surgery, 
including a  lower post-operative pain level, earlier 
mobilization of the patient and shorter length of 
hospital stay, are well known [16]. This also applies 
to the patients in the present study, in whom lapa-
roscopy was associated with a shorter hospital stay 
and reduced intra-operative blood loss. Similar ob-
servations were also made by other authors [17, 18]. 
When analyzing the results of laparoscopic treat-
ment, the number and type of complications seem 
to be key factors. According to the literature, com-
plication rates for this method range from several 
to a dozen or so percent, pulmonary complications 
(pneumonia, pulmonary embolism) being the most 
frequently reported type [3, 17]. In the present study, 
perioperative complications were reported for 13% 
of the patients who underwent laparoscopic surgery 
(group 1). This rate was significantly lower than in 
the group treated via open surgery (41%). It should 
be emphasized that the vast majority of all com-
plications were grade I and II in the Clavien-Dindo 
classification and did not require surgical interven-
tion; only two patients from group 1 had grade III 
complications and required reoperation. However, 
it is important to underline that tumors removed in 
patients from group 2 were larger and had higher 
potential for malignancy, which might have affected 
the complication rate in this group.
In the case of GIST removal, the rate of conver-
sion from laparoscopy to laparotomy appears to be 
low. In their paper, Roggin and Posner present a re-
view of results from five reports on the laparoscop-
ic treatment of GISTs. According to this source, the 
conversion rates range from 0 to 6.5% [3]. In the 
present study, not a single case of conversion to lap-
arotomy was found. At the same time, no intra-op-
erative tumor rupture occurred, a noteworthy result 
given the fact that tumor rupture is a very significant 
prognostic factor for the recurrence of GIST. It ap-
pears that this complication can be avoided provid-
ed that the appropriate surgical technique is applied 
and the tissues are dissected in a sufficiently careful 
manner [19].
The analysis of a significant amount of data re-
vealed no statistically significant differences in the 
5-year survival rates of patients treated with either 
of these techniques [20, 21]. In the present study, 
the median post-surgery follow-up was just under 
5 years. The survival rate in the group treated via 
laparoscopy was 93.4%. None of the three deaths 
in the study group was due to neoplasm. Kim et al. 
reported a 5-year survival rate of 98.6% and 94.8% 
of patients without progression of the disease. None 
of the patients who underwent laparoscopic surgery 
received adjuvant treatment with tyrosine kinase in-
hibitors, and no recurrences were observed. Adjuvant 
therapy with imatinib is recommended in the case 
of GISTs with a very high risk of recurrence [9, 22]. 
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Two patients treated laparoscopically met inclusion 
criteria for adjuvant treatment, but did not receive it 
due to advanced age and comorbidities. These pa-
tients died during the follow-up period for reasons 
unrelated to the progression of GIST. In the group 
analyzed in this study, GIST metastasized to the liver 
in five patients treated with open surgery (incidence 
of 22.7%). In all these patients GIST had a high risk 
of relapse, which was more frequently observed in 
the group of patients undergoing laparotomy. All 
these patients received imatinib after the diagnosis 
of progression and had stable disease at the end of 
the 5-year follow-up.
Conclusions
Laparoscopy in the treatment of gastric GIST has 
similar efficacy as the classical open surgery. Mini-
mally invasive procedures have unquestionable ad-
vantages, including decreased blood loss, reduced 
risk of complications, and shorter hospital stay. The 
team’s experience seems to be the most important 
factor reducing the incidence of complications and 
enabling safe extension of the use of laparoscopy to 
the treatment of oncological patients.
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